tokens: Following an initial report identifying a CHEK2 mutation in a family expressing characteristics of the Li - Fraumeni syndrome [ 65 ] , recent evidence has linked CHEK2 founder mutations to a moderately increased risk of breast - and colorectal cancers with some additional disposition for other malignancies as well [ 66 ] .